Evista, Raloxifene News

The FDA is pushing along two new treatments that could potentially help people living with cervical cancer and paralysis.

Mad rantings about politics, evolution, and microbiology. Comment policy: say what you want, but back it up with an email address.

To read this article in full you must have registered and have a Premium Content Subscription with the NHS Choices site.

Two of the drugs, currently used to treat breast cancer, were found to eliminate the disease in mice.

Two FDA-approved drugs, one used to treat breast cancer and the other to treat osteoporosis, may eventually be used to stop cervical cancer in its tracks.

Cervical cancer could be wiped out by "pioneering use of 'amazing' osteoporosis drugs", the Daily Mail has declared.

Reality TV star Jade Goody died from cervical cancer earlier this year. Now scientists believe a breast cancer drug could beat the disease Cervical cancer can be destroyed by drugs used to treat breast cancer and osteoporosis, a study suggests.

Two drugs used to treat breast cancer and osteoporosis eliminated cervical cancer in mice, according to a new study.

We read with great interest the subgroup analyses of the Raloxifene use for the Heart trial.1 Although this post hoc analysis did not show benefit of raloxifene for any prespecified group, we believe that one particular subgroup, not defined in this study, may benefit from raloxifene in the reduction of coronary outcomes.

You cannot control some things that put you at risk for breast cancer , such as your age and being female.

Eli Lilly & Co. lost a bid for a hearing before Canadaa s highest court on whether its patent for the Evista osteoporosis treatment is valid as the company tried to block Apotex Inc.

My mother ,71 years old, has been use Steroid drug for serious Asthma for many years.

In his article about chemoprevention of breast cancer, Dr. Goldstein provided relative-risk tables.

Canada: The Federal Court Of Appeal Recently Released An Important Decision On The Doctrine Of Sound Prediction and David Tait Facts Eli Lilly's '356 patent claims raloxifene and other benzothiophenes for use in treating or preventing osteoporosis or bone loss, particularly in post-menopausal females, and particularly without eliciting significant ...

Teva Pharmaceutical Industries Ltd. announced that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA's Orange Book for Eli Lilly's Evista Tablets in litigation concerning Teva's abbreviated new drug application to market a generic version.

A federal judge in Indianapolis turned back a patent challenge to Eli Lilly and Co.'s drug Evista, the company announced late yesterday.

Eli Lilly & Co. won a ruling on the validity of patents for its Evista osteoporosis treatment, blocking an attempt by Teva Pharmaceutical Industries Ltd.

The U.S. District Court for the Southern District of Indiana today upheld Eli Lilly and Company's method-of-use patents on Evista .

Earnings Estimates Revisions They're the most powerful force driving stock prices, and the key to the Zacks Rank's market-beating track record.

Three drugs that reduce a woman's chance of getting breast cancer also have been shown to cause adverse effects, according to a new report from the Agency for Healthcare Research and Quality , U.S. Department of Health & Human Services.